Skip to main content
ABEONA THERAPEUTICS INC. logo

ABEONA THERAPEUTICS INC. — Investor Relations & Filings

Ticker · ABEO ISIN · US00289Y2063 LEI · 54930002Z8PIJRCB4576 US Manufacturing
Filings indexed 1,022 across all filing types
Latest filing 2026-05-13 Interim / Quarterly Rep…
Country US United States of America
Listing US ABEO

About ABEONA THERAPEUTICS INC.

https://abeonatherapeutics.com/

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company that develops cell and gene therapies for serious and life-threatening rare diseases. The company's pipeline targets a range of genetic disorders, including recessive dystrophic epidermolysis bullosa (RDEB) and various ophthalmic conditions such as X-linked retinoschisis, Stargardt disease, and autosomal dominant optic atrophy. Abeona also has partnered programs in early clinical development for Sanfilippo syndrome and Batten disease. The company operates its own manufacturing facility, The Elisa Linton Center for Rare Disease Therapies, to support the development of its therapeutic candidates.

Recent filings

Filing Released Lang Actions
10-Q - ABEONA THERAPEUTICS INC. (0000318306) (Filer)
Interim / Quarterly Report
2026-05-13 English
8-K - ABEONA THERAPEUTICS INC. (0000318306) (Filer)
Regulatory Filings
2026-05-13 English
DEFA14A
Proxy Solicitation & Information Statement
2026-05-04 English
Major Shareholding Notification 2026
Major Shareholding Notification
2026-04-28 English
ARS - ABEONA THERAPEUTICS INC. (0000318306) (Filer)
Annual Report
2026-04-27 English
DEF 14A - ABEONA THERAPEUTICS INC. (0000318306) (Filer)
Proxy Solicitation & Information Statement
2026-04-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.